Literature DB >> 28976288

The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.

Orna Levran1, Einat Peles2,3, Matthew Randesi1, Joel Correa da Rosa4, Miriam Adelson1,2,5, Mary Jeanne Kreek1.   

Abstract

AIM: This study assesses whether opioid-related gene variants contribute to reduced vulnerability to relapse to heroin in persons who are not treated with μ-opioid receptor agonist.
METHODS: Genotypes of 71 SNPs, in nine genes, were analyzed for association with long-term abstinence in former heroin-dependents of European/Middle Eastern ancestry, either without agonist treatment (n = 129) or in methadone maintenance treatment (n = 922).
RESULTS: The functional OPRM1 nonsynonymous SNP rs1799971 (118A>G) showed significant association with long-term abstinence (Ppermutation  = 0.03, dominant model, OR: 2.2; 95% CI: 1.5-3.3).
CONCLUSION: Since the stress axis is regulated in part by β-endorphin, this functional OPRM1 SNP may blunt the endogenous stress response and contribute to reduced vulnerability for relapse.

Entities:  

Keywords:  HPA axis; abstinence; heroin addiction; opioids; rs1799971; stress; μ-opioid receptor

Mesh:

Substances:

Year:  2017        PMID: 28976288     DOI: 10.2217/pgs-2017-0092

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

1.  Genetic variations in genes of the stress response pathway are associated with prolonged abstinence from heroin.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Pei-Hong Shen; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2018-02-21       Impact factor: 2.533

2.  Genetic Variants Associated With Resilience in Human and Animal Studies.

Authors:  Stephanie Cahill; Tarani Chandola; Reinmar Hager
Journal:  Front Psychiatry       Date:  2022-05-20       Impact factor: 5.435

Review 3.  Current status of opioid addiction treatment and related preclinical research.

Authors:  M J Kreek; B Reed; E R Butelman
Journal:  Sci Adv       Date:  2019-10-02       Impact factor: 14.136

4.  Associations among the opioid receptor gene (OPRM1) A118G polymorphism, psychiatric symptoms, and quantitative EEG in Korean males with gambling disorder: A pilot study.

Authors:  Kyoung Min Kim; Sam-Wook Choi; Dohyun Kim; Jaewon Lee; Jun Won Kim
Journal:  J Behav Addict       Date:  2019-09-25       Impact factor: 6.756

5.  Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Authors:  Laura R Lander; Vincent Setola; Shane W Kaski; Stephan Brooks; Sijin Wen; Marc W Haut; David P Siderovski; James H Berry
Journal:  J Opioid Manag       Date:  2019 Mar-Apr

6.  Effects of OPRM1 and ABCB1 gene polymorphisms on the analgesic effect and dose of sufentanil after thoracoscopic-assisted radical resection of lung cancer.

Authors:  Zhonghai Zhao; Bin Lv; Xiaodong Zhao; Yunlong Zhang
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

Review 7.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.